AU2018313892B2 - Immunodeficient mice expressing human interleukin 15 - Google Patents

Immunodeficient mice expressing human interleukin 15 Download PDF

Info

Publication number
AU2018313892B2
AU2018313892B2 AU2018313892A AU2018313892A AU2018313892B2 AU 2018313892 B2 AU2018313892 B2 AU 2018313892B2 AU 2018313892 A AU2018313892 A AU 2018313892A AU 2018313892 A AU2018313892 A AU 2018313892A AU 2018313892 B2 AU2018313892 B2 AU 2018313892B2
Authority
AU
Australia
Prior art keywords
cells
mouse
human
immunodeficient
xenogeneic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018313892A
Other languages
English (en)
Other versions
AU2018313892A1 (en
Inventor
Michael A. Brehm
Dale L. Greiner
Leonard D. Shultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jackson Laboratory
University of Massachusetts Amherst
Original Assignee
Jackson Laboratory
University of Massachusetts Amherst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson Laboratory, University of Massachusetts Amherst filed Critical Jackson Laboratory
Publication of AU2018313892A1 publication Critical patent/AU2018313892A1/en
Assigned to THE JACKSON LABORATORY, UNIVERSITY OF MASSACHUSETTS reassignment THE JACKSON LABORATORY Amend patent request/document other than specification (104) Assignors: THE JACKSON LABORATORY, UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Application granted granted Critical
Publication of AU2018313892B2 publication Critical patent/AU2018313892B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2018313892A 2017-08-09 2018-08-09 Immunodeficient mice expressing human interleukin 15 Active AU2018313892B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762543218P 2017-08-09 2017-08-09
US62/543,218 2017-08-09
US201762554818P 2017-09-06 2017-09-06
US62/554,818 2017-09-06
PCT/US2018/046021 WO2019032836A1 (en) 2017-08-09 2018-08-09 IMMUNODEFICIENT MOUSE EXPRESSING THE HUMAN INTERLEUKINE 15

Publications (2)

Publication Number Publication Date
AU2018313892A1 AU2018313892A1 (en) 2020-02-20
AU2018313892B2 true AU2018313892B2 (en) 2024-04-18

Family

ID=63557672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018313892A Active AU2018313892B2 (en) 2017-08-09 2018-08-09 Immunodeficient mice expressing human interleukin 15

Country Status (10)

Country Link
US (1) US20200236916A1 (cg-RX-API-DMAC7.html)
EP (1) EP3664603B1 (cg-RX-API-DMAC7.html)
JP (1) JP7404237B2 (cg-RX-API-DMAC7.html)
KR (1) KR102693739B1 (cg-RX-API-DMAC7.html)
CN (2) CN112118734A (cg-RX-API-DMAC7.html)
AU (1) AU2018313892B2 (cg-RX-API-DMAC7.html)
CA (1) CA3072331A1 (cg-RX-API-DMAC7.html)
IL (1) IL272475B2 (cg-RX-API-DMAC7.html)
SG (1) SG11202001109PA (cg-RX-API-DMAC7.html)
WO (1) WO2019032836A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018102546A1 (en) 2016-11-30 2018-06-07 The Jackson Laboratory Humanized mouse model with improved human innate immune cell development
WO2021150936A1 (en) * 2020-01-22 2021-07-29 City Of Hope Oncolytic virus compositions including il-15 complex and methods for the treatment of cancer
WO2021159035A1 (en) 2020-02-07 2021-08-12 City Of Hope Oncolytic virus compositions and methods for the treatment of cancer
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
CN114304065A (zh) * 2021-12-31 2022-04-12 江苏大学 一种阻断il-8联合抗pd-1抗体治疗胃癌的动物模型构建及应用
WO2024029561A1 (ja) * 2022-08-02 2024-02-08 学校法人東海大学 担がん-免疫不全非ヒト動物、これを用いた供試物質に関するがん免疫応答評価方法
AU2023338373A1 (en) * 2022-09-08 2025-04-03 The Jackson Laboratory Humanized immunodeficient mouse models

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016189799A1 (ja) * 2015-05-27 2016-12-01 公益財団法人実験動物中央研究所 ヒトil-15分泌免疫不全マウス

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
JP6492095B2 (ja) * 2013-10-15 2019-03-27 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. ヒト化il−15動物
US20150282460A1 (en) * 2014-04-04 2015-10-08 Crown Bioscience Inc. (Taicang) Animal model with human immune system
ES2950399T3 (es) * 2015-04-13 2023-10-09 Regeneron Pharma Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos
TWI810145B (zh) * 2015-06-23 2023-08-01 杰克森實驗室 具有病患衍生之異種移植物之非hla配對的人源化nsg小鼠模式

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016189799A1 (ja) * 2015-05-27 2016-12-01 公益財団法人実験動物中央研究所 ヒトil-15分泌免疫不全マウス

Also Published As

Publication number Publication date
US20200236916A1 (en) 2020-07-30
EP3664603B1 (en) 2024-01-03
CA3072331A1 (en) 2019-02-14
EP3664603A1 (en) 2020-06-17
IL272475A (en) 2020-03-31
JP7404237B2 (ja) 2023-12-25
CN116998459A (zh) 2023-11-07
KR102693739B1 (ko) 2024-08-13
IL272475B2 (en) 2025-05-01
AU2018313892A1 (en) 2020-02-20
SG11202001109PA (en) 2020-03-30
KR20200135274A (ko) 2020-12-02
IL272475B1 (en) 2025-01-01
WO2019032836A1 (en) 2019-02-14
CN112118734A (zh) 2020-12-22
JP2021500918A (ja) 2021-01-14

Similar Documents

Publication Publication Date Title
US12409237B1 (en) Methods and models for assessing efficacy of immunotherapies
EP3664603B1 (en) Immunodeficient mice expressing human interleukin 15
US11778994B2 (en) NSG mice lacking MHC class I and class II
EP2618656B1 (en) HUMAN SIRPalpha TRANSGENIC ANIMALS AND THEIR METHODS OF USE
CN119836230A (zh) 具有人源化clec9a基因的非人动物
CN108471732A (zh) 与肿瘤分析相关的组合物和方法
CA2720567A1 (en) Transgenic non-human animal and methods for stem cell engraftment
WO2025171307A1 (en) Vectors, genetically modified cells, and genetically modified non-human animals comprising the same

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: UNIVERSITY OF MASSACHUSETTS

Free format text: FORMER NAME(S): THE JACKSON LABORATORY; UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL

Owner name: THE JACKSON LABORATORY

Free format text: FORMER NAME(S): THE JACKSON LABORATORY; UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL

FGA Letters patent sealed or granted (standard patent)